English | Español

National Academies of Sciences, Engineering and Medicine
+ Community
Bree Gonzales | Feb 4, 2022

Study shows lack of care for U.S. traumatic brain injury patients: ‘We as physicians are frustrated’
+ Regulatory
John Breslin | Dec 20, 2017

Health care experts call for more transparency into PBMs
+ Regulatory
Keri Carbaugh | Jan 18, 2017

Researchers link heart attacks, schizophrenia to marijuana use

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes